Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
6.04
+0.32 (5.59%)
Apr 6, 2026, 4:00 PM EDT - Market closed

Addex Therapeutics Revenue

Addex Therapeutics had revenue of 49.60K CHF in the quarter ending September 30, 2025, a decrease of -14.99%. This brings the company's revenue in the last twelve months to 158.54K, down -73.24% year-over-year. In the year 2024, Addex Therapeutics had annual revenue of 410.04K, down -74.64%.

Revenue (ttm)
158.54K CHF
Revenue Growth
-73.24%
P/S Ratio
31.44
Revenue / Employee
79,269 CHF
Employees
2
Market Cap
6.25M USD

Revenue Chart

* This company reports financials in CHF.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024410.04K-1.21M-74.64%
Dec 31, 20231.62M172.23K11.92%
Dec 31, 20221.44M-1.71M-54.18%
Dec 31, 20213.15M-725.84K-18.71%
Dec 31, 20203.88M1.05M36.89%
Dec 31, 20192.83M-3.87M-57.72%
Dec 31, 20186.70M6.20M1,240.82%
Dec 31, 2017499.89K373.24K294.70%
Dec 31, 2016126.65K-348.97K-73.37%
Dec 31, 2015475.63K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition